Thus, we demonstrate susceptibility to MASH in IL-33-deficient male mice derived from a BALB/c background following immunization with a CYP2E1 epitope that promotes oxidative stress, inflammation, and inhibition of mitochondrial complex 1. Here, IL33 is linked to metabolic dysfunction-associated steatohepatitis.